These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32341047)

  • 1. Text messages for primary prevention of cardiovascular disease: the TextMe2 randomised controlled trial protocol.
    Klimis H; Thiagalingam A; Chow CK
    BMJ Open; 2020 Apr; 10(4):e036767. PubMed ID: 32341047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol.
    Chow CK; Thiagalingam A; Santo K; Kok C; Thakkar J; Stepien S; Billot L; Jan S; Joshi R; Hillis GS; Brieger D; Chew DP; Rådholm K; Atherton JJ; Bhindi R; Collins N; Coverdale S; Hamilton-Craig C; Kangaharan N; Maiorana A; McGrady M; Shetty P; Thompson P; Rogers A; Redfern J
    BMJ Open; 2018 Jan; 8(1):e019463. PubMed ID: 29374674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Text messages for primary prevention of cardiovascular disease: The TextMe2 randomized clinical trial.
    Klimis H; Thiagalingam A; McIntyre D; Marschner S; Von Huben A; Chow CK
    Am Heart J; 2021 Dec; 242():33-44. PubMed ID: 34428440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ITM support for patients with chronic respiratory and cardiovascular diseases: a protocol for a randomised controlled trial.
    Redfern J; Hyun K; Singleton A; Hafiz N; Raeside R; Spencer L; Carr B; Caterson I; Cullen J; Ferry C; Santo K; Hayes A; Leung RWM; Raadsma S; Swinbourne J; Cho JG; King M; Roberts M; Kok C; Jenkins C; Chow C
    BMJ Open; 2019 Mar; 9(3):e023863. PubMed ID: 30826759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes.
    Huo X; Spatz ES; Ding Q; Horak P; Zheng X; Masters C; Zhang H; Irwin ML; Yan X; Guan W; Li J; Li X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    BMJ Open; 2017 Dec; 7(12):e018302. PubMed ID: 29273661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Text messaging support for patients with diabetes or coronary artery disease (SupportMe): protocol for a pragmatic randomised controlled trial.
    Cheung NW; Redfern J; Thiagalingam A; Hng TM; Islam SMS; Haider R; Faruquie S; Chow C;
    BMJ Open; 2019 Jun; 9(6):e025923. PubMed ID: 31221870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a customised mobile phone text messaging intervention supported by data from activity monitors for improving lifestyle factors related to the risk of type 2 diabetes among women after gestational diabetes: protocol for a multicentre randomised controlled trial (SMART MUMS with smart phones 2).
    Marschner S; Chow C; Thiagalingam A; Simmons D; McClean M; Pasupathy D; Smith BJ; Flood V; Padmanabhan S; Melov S; Ching C; Cheung NW
    BMJ Open; 2021 Sep; 11(9):e054756. PubMed ID: 34535488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted, structured text messaging to improve dietary and lifestyle behaviours for people on maintenance haemodialysis (KIDNEYTEXT): study protocol for a randomised controlled trial.
    Stevenson J; Campbell KL; Brown M; Craig J; Howard K; Howell M; Khalid R; Sud K; Teixeira-Pinto A; Thiagalingam A; Tong A; Chow C; Lee VW
    BMJ Open; 2019 May; 9(5):e023545. PubMed ID: 31061013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized Clinical Trial.
    Chow CK; Redfern J; Hillis GS; Thakkar J; Santo K; Hackett ML; Jan S; Graves N; de Keizer L; Barry T; Bompoint S; Stepien S; Whittaker R; Rodgers A; Thiagalingam A
    JAMA; 2015 Sep 22-29; 314(12):1255-63. PubMed ID: 26393848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol.
    Bermon A; Uribe-Rodríguez AF; Pérez-Rivero PF; Prieto-Merino D; Cáceres Rivera DI; Guio E; Atkins L; Horne R; Murray E; Serrano Díaz NC; Free C; Perel P; Casas JP
    BMJ Open; 2019 Dec; 9(12):e028017. PubMed ID: 31818831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol.
    Chow CK; Redfern J; Thiagalingam A; Jan S; Whittaker R; Hackett M; Graves N; Mooney J; Hillis GS
    BMJ Open; 2012; 2(1):e000606. PubMed ID: 22267690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled trial of a consumer-focused e-health strategy for cardiovascular risk management in primary care: the Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) study protocol.
    Redfern J; Usherwood T; Harris MF; Rodgers A; Hayman N; Panaretto K; Chow C; Lau AY; Neubeck L; Coorey G; Hersch F; Heeley E; Patel A; Jan S; Zwar N; Peiris D
    BMJ Open; 2014 Jan; 4(2):e004523. PubMed ID: 24486732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A text message intervention to support women's physical and mental health after breast cancer treatments (EMPOWER-SMS): a randomised controlled trial protocol.
    Singleton A; Partridge SR; Raeside R; Regimbal M; Hyun KK; Chow CK; Sherman K; Elder E; Redfern J
    BMC Cancer; 2019 Jul; 19(1):660. PubMed ID: 31272399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Text2PreventCVD: protocol for a systematic review and individual participant data meta-analysis of text message-based interventions for the prevention of cardiovascular diseases.
    Chow CK; Islam SM; Farmer A; Bobrow K; Maddision R; Whittaker R; Dale LP; Lechner A; Niessen L; Lear SA; Eapen ZJ; Santo K; Stepien S; Redfern J; Rodgers A
    BMJ Open; 2016 Oct; 6(10):e012723. PubMed ID: 27798018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease.
    Adler AJ; Martin N; Mariani J; Tajer CD; Owolabi OO; Free C; Serrano NC; Casas JP; Perel P
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011851. PubMed ID: 28455948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. While you're waiting, a waiting room-based, cardiovascular disease-focused educational program: protocol for a randomised controlled trial.
    Mcintyre D; Thiagalingam A; Chow C
    BMJ Open; 2020 Oct; 10(10):e036780. PubMed ID: 33082181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theory-based mobile phone text messaging intervention for blood pressure control (TEXT4BP) among hypertensive patients in Nepal: study protocol for a feasibility randomised controlled trial.
    Bhandari B; Narasimhan P; Vaidya A; Jayasuriya R
    BMJ Open; 2020 Sep; 10(9):e040799. PubMed ID: 32873686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A healthy lifestyle text message intervention for adolescents: protocol for the Health4Me randomized controlled trial.
    Raeside R; Spielman K; Maguire S; Mihrshahi S; Steinbeck K; Kang M; Laranjo L; Hyun K; Redfern J; Partridge SR;
    BMC Public Health; 2022 Sep; 22(1):1805. PubMed ID: 36138375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of text messaging on depression in patients with coronary heart disease: a substudy analysis from the TEXT ME randomised controlled trial.
    Shariful Islam SM; Chow CK; Redfern J; Kok C; Rådholm K; Stepien S; Rodgers A; Hackett ML
    BMJ Open; 2019 Feb; 9(2):e022637. PubMed ID: 30787075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Text Messaging on Risk Factor Management in Patients With Coronary Heart Disease: The CHAT Randomized Clinical Trial.
    Zheng X; Spatz ES; Bai X; Huo X; Ding Q; Horak P; Wu X; Guan W; Chow CK; Yan X; Sun Y; Wang X; Zhang H; Liu J; Li J; Li X; Spertus JA; Masoudi FA; Krumholz HM
    Circ Cardiovasc Qual Outcomes; 2019 Apr; 12(4):e005616. PubMed ID: 30998400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.